Prevalence of fentanyl exposure and knowledge regarding the risk of its use among emergency department patients with active opioid use history at an urban medical center in Baltimore, Maryland

References

• Denton JS, Donoghue ER, McReynolds J, et al. An epidemic of illicit fentanyl deaths in Cook County, Illinois: September 2005 through April 2007. J Forensic Sci. 2008;53:452–454.
   PubMed Web of Science ®Google Scholar
• Schumann H, Erickson T, Thompson TM, et al. Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. Clin Toxicol. 2008;46:501–506.
   PubMed Web of Science ®Google Scholar
• Lucyk SN, Nelson LS. Novel synthetic opioids: an opioid epidemic within an opioid epidemic. Ann Emerg Med. 2017;69:91–93.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Nonpharmaceutical fentanyl-related deaths – multiple states, April 2005–March 2007. MMWR Morb Mortal Wkly Rep. 2008;57:793–796.
   PubMedGoogle Scholar
• National Institute on Drug Abuse. Overdose death rates; [cited 2019 Jan 22]. Available from: https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates
   Google Scholar
• O'Donnell JK, Gladden RM, Seth P. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region – United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017;66:897–903.
   PubMed Web of Science ®Google Scholar
• Scholl L, Seth P, Kariisa M, et al. Drug and opioid-involved overdose deaths – United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2018;67:1419–1427.
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention. Understanding the epidemic; [cited 2019 Jan 10]. Available from: https://www.cdc.gov/drugoverdose/epidemic/index.html
   Google Scholar
• US Department of Justice DEA. National Forensic Laboratory Information System Brief: fentanyl, 2001–2015; 2018. p. 1–2.
   Google Scholar
• Drug Enforcement Administration, U.S. Department of Justice, Division DC. National Forensic Laboratory Information System: NFLIS-drug 2017 annual report; 2019. p. 1–32.
   Google Scholar
• O'Donnell JK, Halpin J, Mattson CL, et al. Deaths involving fentanyl, fentanyl analogs, and U-47700 – 10 states, July–December 2016. MMWR Morb Mortal Wkly Rep. 2017;66:1197–1202.
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration, U.S. Department of Justice, Division DC. NFLIS brief: fentanyl and fentanyl-related substances reported in NFLIS, 2015–2016; 2018. p. 1–2.
   Google Scholar
• Griswold MK, Chai PR, Krotulski AJ, et al. Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose. Clin Toxicol. 2018;56:37–42.
   PubMed Web of Science ®Google Scholar
• Silverstein JH, Rieders MF, McMullin M, et al. An analysis of the duration of fentanyl and its metabolites in urine and saliva. Anesth Analg. 1993;76:618–621.
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration, U.S. Department of Justice. 2017 National Drug Threat Assessment; [cited 2019 Jan 14]. Available from: https://www.dea.gov/documents/2017/10/01/2017-national-drug-threat-assessment
   Google Scholar
• Jones AA, Jang K, Panenka WJ, et al. Rapid change in fentanyl prevalence in a community-based, high-risk sample. JAMA Psychiatry. 2018;75:298–300.
   PubMed Web of Science ®Google Scholar
• Krieger MS, Goedel WC, Buxton JA, et al. Use of rapid fentanyl test strips among young adults who use drugs. Int J Drug Policy. 2018;61:52–58.
   PubMed Web of Science ®Google Scholar
• Amlani A, McKee G, Khamis N, et al. Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduct J. 2015;12:54.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Milloy MJ, Lysyshyn M, et al. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: a cross-sectional urine toxicology screening study. Drug Alcohol Depend. 2018;183:1–6.
   PubMed Web of Science ®Google Scholar
• Actavis Totowa LLC. Withdrawal of approval of abbreviated new drug applications for prescription pain medications containing more than 325 milligrams of acetaminophen. Federal Register. 2014;79:17163–17168.
   Google Scholar
• Dezman ZDW, Felemban W, Bontempo LJ, et al. Evidence of fentanyl use is common and frequently missed in a cross-sectional study of emergency department patients in Baltimore, Maryland. Clin Toxicol. 2019;1–3.
   Web of Science ®Google Scholar
• Karamouzian M, Dohoo C, Forsting S, et al. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduct J. 2018;15:46.
   PubMed Web of Science ®Google Scholar
• Tupper KW, McCrae K, Garber I, et al. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend. 2018;190:242–245.
   PubMed Web of Science ®Google Scholar
• Maryland Department of Health. Unintentional Drug- and alcohol-related intoxication deaths in Maryland Annual Report 2017; 2018; [cited 2019 Mar 1]. Available from: https://bha.health.maryland.gov/OVERDOSE_PREVENTION/Documents/Drug_Intox_Report_2017.pdf
   Google Scholar
• Griswold MK, Chai PR, Krotulski AJ, et al. Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose. Clin Toxicol. 2017;63:1–6.
   Google Scholar
• Daniulaityte R, Juhascik MP, Strayer KE, et al. Overdose deaths related to fentanyl and its analogs – Ohio, January–February 2017. MMWR Morb Mortal Wkly Rep. 2017;66:904–908.
   PubMed Web of Science ®Google Scholar
• Daniulaityte R, Juhascik MP, Strayer KE, et al. Trends in fentanyl and fentanyl analogue-related overdose deaths – Montgomery County, Ohio, 2015–2017. Drug Alcohol Depend. 2019;198:116–120.
   PubMed Web of Science ®Google Scholar
• Dai Z, Abate MA, Smith GS, et al. Fentanyl and fentanyl-analog involvement in drug-related deaths. Drug Alcohol Depend. 2019;196:1–8.
   PubMed Web of Science ®Google Scholar
• Ma J, Bao Y-P, Wang R-J, et al. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry. 2018;382:1564.
   Google Scholar
• Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169:137–145.
   PubMed Web of Science ®Google Scholar
• Schwartz RP, Gryczynski J, O’Grady KE, et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009. Am J Public Health. 2013;103:917–922.
   PubMed Web of Science ®Google Scholar